SKYE ALTIERI: Open Payments
NPI 1821635475 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 31 payments from 8 companies in 2025. Trend: 2023 $396 · 2024 $319 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $198 |
| Phathom Pharmaceuticals, Inc. | 4 | $88 |
| Celltrion USA Inc. | 4 | $68 |
| Madrigal Pharmaceuticals | 2 | $41 |
| QOL Medical, LLC | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: TREMFYA, VOQUEZNA, VEGZELMA, REZDIFFRA, Sucraid, ZENPEP, ENTYVIO.
Industry payments across TX — which companies pay providers there.
